LH
NYSELABCORP HOLDINGS INC.
Healthcare · Services-Medical Laboratories
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
$13.1B
2021
$11.9B
2022
$12.2B
2023
$13.0B
2024
$14.0B
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$14.0B
Net Income$877.7M
Gross Profit$4.0B
Oper Income$1.4B
EPS (dil)$10.46
Rev/sh$170.14
FCF/sh$14.71
Book/sh$105.12
Gross M28.8%
Oper M9.9%
Profit M6.3%
FCF M8.6%
ROE10.2%
ROA4.8%
ROIC8.0%
R&D/Rev—
Rev Y/Y7.2%
Rev 3Y CAGR5.6%
EPS Y/Y18.3%
EPS 3Y CAGR-9.2%
FCF 3Y CAGR-7.6%
Payout27%
Div/sh—
Shs Chg Y/Y-0.7%
Current Ratio1.42
Quick Ratio1.23
Debt/Eq0.65
Int Coverage6.2×
Net Debt$5.1B
Total Debt$5.6B
Cash & Eq$532.3M
Total Assets$18.4B
Oper CF$1.6B
Capex$434.5M
Free CF$1.2B
Buybacks$450.0M
Equity$8.6B
Liabilities$9.8B
Shs Outstand0.08B
SectorHealthcare
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $13.1B | $11.9B | $12.2B | $13.0B | $14.0B |
| Gross Profit | $5.0B | $3.7B | $3.4B | $3.6B | $4.0B |
| Operating Income | $3.0B | $1.4B | $725.6M | $1.1B | $1.4B |
| Net Income | $2.4B | $1.3B | $419.2M | $747.1M | $877.7M |
| Diluted EPS | $24.39 | $13.97 | $4.77 | $8.84 | $10.46 |
| Operating Cash Flow | $3.1B | $2.0B | $1.2B | $1.6B | $1.6B |
| Free Cash Flow | $2.7B | $1.5B | $748.7M | $1.1B | $1.2B |
COMMUNITY · $LH0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.